Skip to content

Impact of Human Embryo Culture System on Live Birth

Improvement of Live Birth Rate With a New Standardized Human Embryo Culture System: a Prospective, Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01904006
Acronym
AGRUPADO
Enrollment
182
Registered
2013-07-19
Start date
2013-07-23
Completion date
2016-10-31
Last updated
2018-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Embryo Culture

Keywords

grouped embryo culture, embryo density, low oxygen, benchtop incubator, culture condition

Brief summary

Previous studies in human and different mammals have proved that the embryo group culture (in the same culture medium drop) using a reduced volume is associated with a better embryo development. This is due to the effect of different autocrine and paracrine factors secreted by the embryos. Besides, previous studies with embryos from human and other mammals have shown that a high oxygen concentration may have a negative effect on embryo quality due to the generation of reactive oxygen species, which cause oxidative stress. The embryo culture at low oxygen tension is correlated to better success rates in IVF/ICSI treatments. The purpose of this study is to evaluate the combined effect of the embryo group culture and the low oxygen tension on the embryo development and the results of the IVF/ICSI treatments. The specific goal is to compare the embryo group culture in a reduced volume of medium at a low oxygen tension (5%) with the standard individual culture at an atmospheric oxygen tension (20%). The first culture condition will be applied in a K-MINC incubator (COOK Medical®), whereas the second condition will be applied using a Heracell incubator (Heraeus®).

Interventions

PROCEDURENew Culture Condition

Intervention group embryos cultured grouped (5 embryos per drop) under low oxygen tension (5%) in benchtop incubators.

PROCEDUREStandard Culture Condition

Control group embryos cultured individually (1 embryo per drop) under atmospheric oxygen tension (20%) in large-box incubators.

Sponsors

Vida Recoletas Sevilla
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

* \<38 years (with own oocytes) / \<45 years (with oocyte donation). * First treatment with own oocytes / any treatment with oocyte donation. * ≥10 oocytes with a diameter of ≥10 mm.

Exclusion criteria

* Diseases that affect endometrial receptivity: endometriosis, hydrosalpinx, ovarian hyperstimulation syndrome, obesity, endocrinopathies, thrombophilia, congenital or acquired uterine anomalies. * Patients under a treatment with genetic preimplantation diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy rateApril 2013 - October 2016Confirmed when a gestational sac with heartbeat was observed in the uterus by ultrasound examination, performed 2-3 weeks after the positive result of the beta-hCG pregnancy test.

Secondary

MeasureTime frameDescription
Implantation rateApril 2013 - October 2016Number of embryos implanted per number of embryos transferred
Live birth rateApril 2013 - October 2016Number of newborns per pregnancy achieved

Other

MeasureTime frame
Mean number of embryos transferredApril 2013 - October 2016
Live Birth rate per embryos transferredApril 2013 - October 2016
Fecundation rateApril 2013 - October 2016
Clinical miscarriage rateApril 2013 - October 2016
Multiple pregnancy rateApril 2013 - October 2016
Mean number of viable embryosApril 2013 - October 2016
Blastocyst rateApril 2013 - October 2016

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026